TrueBlue, Inc.
corporate_fare Company Profile
TrueBlue, Inc. (NYSE:TBI) is a publicly traded company in the Trade & Services sector. Wiseek has independently scored 20 items for TBI at importance 7 or higher on its 1–10 market-impact scale. Its most recent item scored 7 or higher is dated 2026-08-04, rated 7/10. Across its 20 most recent items scored 7 or higher, the top rating is 9/10, with 16 rated 8 or above. Recent SEC coverage for TBI spans 10-Q, 8-K, 144, DEF 14A.
Recent high-impact activity:
- TrueBlue's Q2 revenue climbs 12%, but margin erosion and impairment charges weigh on the bottom line
- TrueBlue Q2 Revenue Jumps 12%, Adjusted EBITDA Surges to $11M; Guides Q3 Revenue Above Consensus
- Director Files Intent to Sell Shares Valued at $204.9 Million
- TrueBlue Board Unanimously Rejects HireQuest's On-Demand Business Acquisition Proposal
- TrueBlue Shareholders Approve Potentially Dilutive Equity Incentive Plan
Financial Snapshot
Short Interest & Short Volume
2.49 days to coverFINRA reported short interest of 821,435 shares in TBI as of the September 15, 2026 settlement, a 5.9% increase from the prior period — about 2.5 days to cover at its recent average daily volume. On October 2, 2026, 39.0% of TBI volume reported to FINRA trade-reporting facilities was marked short.
Daily short sale volume covers trades reported to FINRA trade-reporting facilities and is not the same as short interest (bi-monthly reported positions). Source: FINRA — FINRA is the owner and source of this short interest and short sale volume data; it may not be redistributed.